The key point is that this is the first randomized, placebo-controlled clinical evidence that a GLP-1 receptor agonist may slow the biological processes associated with aging in humans. Michael Corley, PhD Using multiple epigenetic clocks, we saw a broad pattern of slower biological aging in participants treated with semaglutide compared with placebo, including a 9% slowing in the pace of aging measured by DunedinPACE and a significant effect on PCGrimAge, which tracks processes linked to all-cause mortality and age-related disease, the researcher detailed
Gastrointestinal health improves because the molecule protects against oxidative stress and ulceration
Or it could be that the drugs wont work well enough for these conditions
Medical review helps determine whether medication is appropriate and safe
Soyini Hawkins, MD, and her team of nurse practitioners, associates, medical assistants, and office staff are here to support you on your weight loss journey